{
    "eid": "2-s2.0-85140920894",
    "title": "Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents",
    "cover-date": "2022-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "adolescents",
        "anti-SARS-CoV-2",
        "BNT162b2",
        "booster dose",
        "fractional dose",
        "neutralizing antibody titer",
        "SARS-CoV-2 vaccine"
    ],
    "authors": [
        "Thanyawee Puthanakit",
        "Napaporn Chantasrisawad",
        "Kirana Yoohat",
        "Rapisa Nantanee",
        "Jiratchaya Sophonphan",
        "Thutsanun Meepuksom",
        "Pimpayao Sodsai",
        "Supranee Phanthanawiboon",
        "Watsamon Jantarabenjakul",
        "Nattiya Hirankarn",
        "Pope Kosalaraksa"
    ],
    "citedby-count": 3,
    "ref-count": 38,
    "ref-list": [
        "The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children",
        "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12\u201315 Years\u2014United States, May 2021",
        "Safety, Immunogenicity, and Efficacy of the BNT162b2 COVID-19 Vaccine in Adolescents",
        "Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5\u201311 Years and Adolescents Aged 12\u201315 Years\u2014PROTECT Cohort, July 2021\u2013February 2022",
        "Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices\u2014United States, June 2021",
        "Safety and Immunogenicity of Two RNA-Based COVID-19 Vaccine Candidates",
        "Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial",
        "The Advisory Committee on Immunization Practices\u2019 Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines\u2014United States, 2021",
        "A serological assay to detect SARS-CoV-2 seroconversion in humans",
        "A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Chimeric Virus-like Particle-Based COVID-19 Vaccine Confers Strong Protection against SARS-CoV-2 Viremia in K18-hACE2 Mice",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "COVID-19 vaccine hesitancy and influential factors among Thai parents and guardians to vaccinate their children",
        "Parents\u2019 and Guardians\u2019 Willingness to Vaccinate Their Children against COVID-19: A Systematic Review and Meta-Analysis",
        "Testing fractional doses of COVID-19 vaccines",
        "Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine",
        "Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England",
        "Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: Test-negative design studies from British Columbia and Quebec, Canada",
        "Epidemiology of Myocarditis and Pericarditis following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval among Adolescents and Adults in Ontario, Canada",
        "The T cell immune response against SARS-CoV-2",
        "Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant",
        "BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality",
        "Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine",
        "BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype",
        "Association of Prior BNT162b2 COVID-19 Vaccination with Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance",
        "Immunogenicity of BNT162b2 Vaccination against SARS-CoV-2 Omicron Variant and Attitudes toward a COVID-19 Booster Dose among Healthy Thai Adolescents"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Diseases Control",
        "National Vaccine Institute, Thailand",
        "Chulalongkorn University",
        "Ministry of Public Health, Thailand"
    ]
}